M/18/085 - Uniphar / Bradley-�s Pharmacy Group [2018] IECompA m18085 (16 November 2018)

The Competition and Consumer Protection Commission found that the proposed acquisition would not substantially lessen competition in the relevant markets and therefore cleared the transaction.

Parties: Acquirer: Uniphar Public Limited Company; Target: Pagni Pharmacies Limited; Target: Pyramach Limited trading as Bradley's Pharmacy Group
Jurisdiction: Ireland
Judgment Date: 16 November 2018
Procedural Posture: Merger Control / Phase 1 Clearance
Outcome: cleared
Legal Topics: Merger Control, Pharmaceutical Sector

Competition Law Merger Control Pharmaceutical Sector

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 1 Authorities cited 1 Party arguments 2 Amounts and remedies 1

Parties

Uniphar Public Limited Company

Acquirer

Pagni Pharmacies Limited

Target

Pyramach Limited trading as Bradley's Pharmacy Group

Target

Procedural Posture

Merger Control / Phase 1 Clearance

Legal Issues

1 Whether the proposed acquisition would substantially lessen competition in the supply of pharmaceuticals and operation of community pharmacies in the State

Ratio Decidendi

The Competition and Consumer Protection Commission found that the proposed acquisition would not substantially lessen competition in the relevant markets and therefore cleared the transaction.

Court Disposition

cleared

Orders

Acquisition of sole control by Uniphar plc over Pagni Pharmacies Limited and Pyramach Limited trading as Bradley's Pharmacy Group is approved